Basel Medical Group Ltd Ordinary Shares Net Assets
Basel Medical Group Ltd Ordinary Shares net assets. Based on the latest financial reports, Basel Medical Group Ltd Ordinary Shares (BMGL) has net assets worth $6.52 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($20.12 Million) and total liabilities ($13.60 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Basel Medical Group Ltd Ordinary Shares (BMGL) net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.52 Million |
| % of Total Assets | 32.42% |
| Annual Growth Rate | 9.49% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 37.3 |
Net Assets of Basel Medical Group Ltd Ordinary Shares (2022–2025)
Net assets of Basel Medical Group Ltd Ordinary Shares from 2022 to 2025. This chart illustrates how Basel Medical Group Ltd Ordinary Shares's net assets have evolved over time, based on quarterly financial data. See debt-free asset ratio of Basel Medical Group Ltd Ordinary Shares to measure how much of total assets are equity-financed.
Annual Net Assets for Basel Medical Group Ltd Ordinary Shares (2022–2025)
The table below shows the annual net assets of Basel Medical Group Ltd Ordinary Shares from 2022 to 2025. For live market cap and overall valuation, see BMGL company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $4.86 Million | -35.67% |
| 2024-06-30 | $7.56 Million | +37.76% |
| 2023-06-30 | $5.49 Million | +48.12% |
| 2022-06-30 | $3.71 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Basel Medical Group Ltd Ordinary Shares's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 218.6% over the analyzed period, potentially due to dividend distributions or operating losses.
Basel Medical Group Ltd Ordinary Shares Net Assets Breakdown (June 2025)
Basel Medical Group Ltd Ordinary Shares net assets breakdown by equity component as of June 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $34.21 Million | 703.73% |
| Other Comprehensive Income | $-24.95 Million | -513.28% |
| Total Equity | $4.86 Million | 100.00% |
Basel Medical Group Ltd Ordinary Shares Competitors by Market Cap
The table below lists competitors of Basel Medical Group Ltd Ordinary Shares ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hanwha Corp. Pfd. Series 1
KO:000885
|
$5.70 Million |
|
Jiankun International Bhd
KLSE:8923
|
$5.70 Million |
|
RealTech AG
XETRA:RTC
|
$5.71 Million |
|
Impex Ferro Tech Limited
NSE:IMPEXFERRO
|
$5.72 Million |
|
PT Sunter Lakeside Hotel Tbk
JK:SNLK
|
$5.70 Million |
|
Dongil Steel Co. Ltd
KQ:023790
|
$5.69 Million |
|
Finetek Co. Ltd
KQ:131760
|
$5.69 Million |
|
BRITANNIA LIFE SCIENCES
F:L020
|
$5.69 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Basel Medical Group Ltd Ordinary Shares's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 7,561,641 to 4,861,042, a change of -2,700,599 (-35.7%).
- Net loss of 12,087,603 reduced equity.
- New share issuances of 9,753,384 increased equity.
- Other comprehensive income decreased equity by 495,739.
- Other factors increased equity by 129,359.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-12.09 Million | -248.66% |
| Share Issuances | $9.75 Million | +200.64% |
| Other Comprehensive Income | $-495.74K | -10.2% |
| Other Changes | $129.36K | +2.66% |
| Total Change | $- | -35.71% |
Book Value vs Market Value Analysis
This analysis compares Basel Medical Group Ltd Ordinary Shares's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.62x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.84x to 1.62x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-06-30 | $2.74 | $5.04 | x |
| 2023-06-30 | $4.05 | $5.04 | x |
| 2024-06-30 | $5.58 | $5.04 | x |
| 2025-06-30 | $3.11 | $5.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Basel Medical Group Ltd Ordinary Shares utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -248.66%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -106.78%
- • Asset Turnover: 0.67x
- • Equity Multiplier: 3.47x
- Recent ROE (-248.66%) is below the historical average (-33.85%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 53.38% | 18.56% | 0.63x | 4.55x | $1.61 Million |
| 2023 | 32.49% | 18.38% | 0.63x | 2.80x | $1.23 Million |
| 2024 | 27.41% | 20.62% | 0.62x | 2.16x | $1.32 Million |
| 2025 | -248.66% | -106.78% | 0.67x | 3.47x | $-12.57 Million |
Industry Comparison
This section compares Basel Medical Group Ltd Ordinary Shares's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $463,282,600
- Average return on equity (ROE) among peers: 3.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Basel Medical Group Ltd Ordinary Shares (BMGL) | $6.52 Million | 53.38% | 2.08x | $5.70 Million |
| Acadia Healthcare Company Inc (ACHC) | $2.17 Billion | 0.28% | 1.78x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $158.93 Million | 7.57% | 0.45x | $1.69 Billion |
| agilon health Inc (AGL) | $-232.03 Million | 0.00% | 0.00x | $1.43 Billion |
| Airsculpt Technologies Inc (AIRS) | $70.77 Million | -20.74% | 1.84x | $124.72 Million |
| Amedisys Inc (AMED) | $397.76 Million | 3.21% | 0.68x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $8.87 Million |
| American Oncology Network Inc. (AONC) | $108.01 Million | -3.68% | 3.35x | $325.24 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $1.66 Billion |
| Astrana Health Inc (ASTH) | $510.64 Million | 13.50% | 0.70x | $1.81 Billion |
About Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental he… Read more